Improving Patient Outcomes with Regorafenib for Metastatic Colorectal Cancer - Patient Selection, Dosing, Patient Education, Prophylaxis, and Management of Adverse Events

Publisher： Karger

E-ISSN： 2296-5262|38|6|300-308

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.6, 2015-05, pp. : 300-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate cancer multidisciplinary care: improving patient outcomes

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 4, 2015-07 ,pp. : 18-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-02 ,pp. : 83-87

Karger

Access to resources Recommend Favorite

Adverse Events During Hospitalization: Results of a Patient Survey

By Fowler Floyd J.   Epstein Arnold   Weingart Saul N.   Annas Catherine L.   Bolcic-Jankovic Dragana   Clarridge Brian   Schneider Eric C.   Weissman Joel S.  

Joint Commission Journal on Quality and Patient Safety, Vol. 34, Iss. 10, 2008-10 ,pp. : 583-590

Joint Commission Resources

Access to resources Recommend Favorite

Patient-Reported Adverse Events: What Are We Waiting For?

By Weingart Saul N.  

Joint Commission Journal on Quality and Patient Safety, Vol. 37, Iss. 11, 2011-11 ,pp. : 494-494

Joint Commission Resources

Access to resources Recommend Favorite

Improving patient outcomes through supervision and simulation

By  

MEDICAL EDUCATION, Vol. 49, Iss. 7, 2015-07 ,pp. : 647-649

John Wiley & Sons Inc

Access to resources Recommend Favorite